About Us  |  BVA-100  |  Investor Relations  |  IDANT Division  |  Contact Us
 

About Us: Management

 
 

4/10/2014 - Dr. Feldschuh, CEO of Daxor, Returned to Work after Fracturing a Hip, Speaks About Extensive Blood Loss; Daxor Will Provide a New Service to Hospitals and Patients

  

2/28/2014 - Daxor Corporation Announces Filing of Form N-CSR for December 31, 2013

  

2/11/2014 - Daxor Corporation Announces Dr. Joseph Feldschuh, President and CEO, Sustained a Fractured Hip, Had Emergency Surgery, and Received a Transfusion of His Own Frozen Blood Which Had Been Stored Four Years Ago

  
 

______________________

 
     
  Form N-CSR for Dec 31, 2013  
  Form N-Q for Sep 30, 2013  
  Form N-CSR for June 30, 2013  
  Form N-Q for Mar 31, 2013  
 

 

 
Executive Team

Joseph Feldschuh, M.D.

President and CEO

David Frankel

Chief Financial Officer

Diane Meegan

Corporate Secretary

Gary Fischman, Ph.D.

Vice President, Research and Development
   
Board of Directors  

Joseph Feldschuh, M.D.

Chairman of the Board

Michael R. Feldschuh

Director of the Company

James A. Lombard

Director of the Company

Martin S. Wolpoff

Director of the Company

Robert Willens

Director of the Company

Bernhard Saxe

Director of the Company
   
Medical Advisory Board  

Philip Frost, M.D.

 

Robert L. Rosenthal, M.D.

 

Fred Gilbert, M.D.

 

James H. Brassel, M.D.

 
Menu Options

DAXOR Home Page

Mission Statement

Privacy Statement

Company Management

Careers

Contact Us

 

 

Corporate
Headquarters

350 Fifth Ave.
Suite 7120
New York, NY 10118
Phone: 212-330-8500
Fax: 212-244-0806


© 2014 DAXOR Corporation. All Rights Reserved.